|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:D417307 |
| 產(chǎn)品名稱:Diazoxide-15N,13C2 |
| 產(chǎn)品CAS:1329613-88-8 |
| 規(guī)格含量:10mg |
| 產(chǎn)品價格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
D417307 |
| 名稱: |
Diazoxide-15N,13C2 |
| 別名: |
7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine-15N,13C2 1,1-Dioxide; 3-Methyl-7-chloro-1,2,4-benzothiadiazine-15N,13C2 1,1-Dioxide; 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine-15N,13C2 1,1-Dioxide; Dizoxide-15N,13C2; Hyperstat-15N,13C2; Hypertonalum-15N,13C2; Mutabase-15N,13C2; NSC 76130-15N,13C2; Proglicem-15N,13C2; Proglycem-15N,13C2; SRG 95213-15N,13C2; Sch 6783-15N,13C2; |
| CAS號: |
1329613-88-8 |
| 參考CAS號: |
364-98-7-未標(biāo)記 |
| 分子式: |
C?¹³C?H?ClN¹?NO?S |
| 分子量: |
233.65 |
| 種類: |
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Labelled Diazoxide (D417305). The compound reduces status epilepticus neuron damage in diabetes. A potassium channel opener |
| 參考文獻 |
|
|
|
|